Akoya (AKYA) Reports In-Line Q2 EPS, provides guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. WCN
7. SPOT
8. SPY
9. FIX
10. TSCO

Go back to Akoya (AKYA) Reports In-Line Q2 EPS, provides guidance

Morgan Stanley Downgrades Akoya Biosciences Inc (AKYA) to Equalweight

August 6, 2024 12:06 PM EDT

Morgan Stanley analyst Tejas Savant downgraded Akoya Biosciences Inc (NASDAQ: AKYA) from Overweight to Equalweight with a price target of $3.00 (from $4.00).

The analyst comments "Guide lowered again despite in-line qtr as placements rebound falls short of expectations on weak capital... More

BTIG Downgrades Akoya Biosciences Inc (AKYA) to Neutral

August 6, 2024 6:02 AM EDT

BTIG analyst Mark Massaro downgraded Akoya Biosciences Inc (NASDAQ: AKYA) from Buy to Neutral.

The analyst comments "AKYA announced its third workforce reduction in 13 months, and lowered its 2024 revenue guidance in back-to-back quarters. Investor concerns have ranged from constrained budgets in the... More